Shaker A Mousa Selected Research

tetraiodothyroacetic acid (TA(4))

01/2008

12	Neoplasms (Cancer) 01/2008 - 02/2002
12	Thrombosis (Thrombus) 07/2007 - 01/2002
2	Neoplasm Metastasis (Metastasis) 10/2007 - 09/2003
1	Retinal Neovascularization 03/2008
1	Vascular Diseases (Vascular Disease) 02/2008
1	Inflammation 07/2007
1	Heart Failure 05/2007
1	Rheumatoid Arthritis 05/2007
1	Thrombocytopenia (Thrombopenia) 04/2007
1	Hepatitis B 01/2007
1	Glioma (Gliomas) 07/2006

6	Low-Molecular-Weight Heparin (Heparin, Low Molecular Weight)IBA 07/2007 - 01/2002
4	Heparin (Liquaemin)FDA LinkGeneric 07/2007 - 08/2002
3	AnticoagulantsIBA 06/2007 - 02/2002
2	HormonesIBA 01/2008 - 07/2006
2	lipoprotein-associated coagulation inhibitor (TFPI)IBA 10/2007 - 01/2004
2	Platelet Aggregation Inhibitors (Antiplatelet Drugs)IBA 06/2007 - 01/2004
2	tinzaparin (Innohep)FDA Link 10/2004 - 01/2002
1	Integrin alphaVIBA 03/2008
1	Retinaldehyde (Retinal)IBA 03/2008
1	Aspirin (Acetylsalicylic Acid)FDA LinkGeneric 02/2008
1	clopidogrel (Plavix)FDA LinkGeneric 02/2008
1	tetraiodothyroacetic acid (TA(4))IBA 01/2008
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 05/2007
1	XV 459IBA 04/2007
1	VaccinesIBA 01/2007
1	Nicotine FDA Link 04/2006
1	resveratrolIBA 01/2005
1	FibrinIBA 01/2005
1	Thromboplastin (Tissue Factor)IBA 01/2004
1	XV 454IBA 09/2003
1	roxifibanIBA 04/2002
1	orbofibanIBA 04/2002
1	Glycoproteins (Glycoprotein)IBA 04/2002